In this study, we extended previous work of exploiting gene expression profiling approach for accurate detection of VEGF downstream biological activity, and designed a more stringent analytical protocol to identify and validate a reliable VEGF-dependent gene signature in preclinical tumor models and in human patients. The gene discussed is VEGFA; the disease is neoplasm.